Berlin - Delayed Quote EUR

G1 Therapeutics Inc (G1H.BE)

3.7060 +0.1120 (+3.12%)
At close: April 26 at 8:30 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
77,888.0000
82,511.0000
51,301.0000
31,476.0000
45,285.0000
Cost of Revenue
6,931.0000
7,195.0000
3,748.0000
2,016.0000
--
Gross Profit
70,957.0000
75,316.0000
47,553.0000
29,460.0000
45,285.0000
Operating Expense
132,442.0000
114,843.0000
183,731.0000
171,917.0000
141,761.0000
Operating Income
-61,485.0000
-39,527.0000
-136,178.0000
-142,457.0000
-96,476.0000
Net Non Operating Interest Income Expense
-8,488.0000
-7,565.0000
-9,684.0000
-4,624.0000
-826.0000
Other Income Expense
1,929.0000
2,240.0000
3.0000
-346.0000
-542.0000
Pretax Income
-68,044.0000
-44,852.0000
-145,859.0000
-147,427.0000
-97,844.0000
Tax Provision
2,694.0000
3,115.0000
1,700.0000
925.0000
1,410.0000
Net Income Common Stockholders
-70,738.0000
-47,967.0000
-147,559.0000
-148,352.0000
-99,254.0000
Diluted NI Available to Com Stockholders
-70,738.0000
-47,967.0000
-147,559.0000
-148,352.0000
-99,254.0000
Basic EPS
-0.93
--
-3.38
-3.54
-2.62
Diluted EPS
-0.93
--
-3.38
-3.54
-2.62
Basic Average Shares
51,733.4870
--
43,626.1130
41,943.4170
37,878.0260
Diluted Average Shares
51,733.4870
--
43,626.1130
41,943.4170
37,878.0260
Total Operating Income as Reported
-61,485.0000
-39,527.0000
-136,178.0000
-142,457.0000
-96,476.0000
Total Expenses
139,373.0000
122,038.0000
187,479.0000
173,933.0000
141,761.0000
Net Income from Continuing & Discontinued Operation
-70,738.0000
-47,967.0000
-147,559.0000
-148,352.0000
-99,254.0000
Normalized Income
-70,738.0000
-47,967.0000
-147,559.0000
-148,352.0000
-99,254.0000
Interest Income
2,422.0000
2,473.0000
748.0000
43.0000
952.0000
Interest Expense
10,910.0000
10,038.0000
10,432.0000
4,667.0000
1,778.0000
Net Interest Income
-8,488.0000
-7,565.0000
-9,684.0000
-4,624.0000
-826.0000
EBIT
-57,134.0000
-34,814.0000
-135,427.0000
-142,760.0000
-96,066.0000
EBITDA
-56,608.0000
-34,301.0000
-134,897.0000
-142,291.0000
-95,484.0000
Reconciled Cost of Revenue
6,931.0000
7,195.0000
3,748.0000
2,016.0000
--
Reconciled Depreciation
526.0000
513.0000
530.0000
469.0000
582.0000
Net Income from Continuing Operation Net Minority Interest
-70,738.0000
-47,967.0000
-147,559.0000
-148,352.0000
-99,254.0000
Normalized EBITDA
-56,608.0000
-34,301.0000
-134,897.0000
-142,291.0000
-95,484.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
12/31/2020 - 5/8/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade